Skip to main content

and
  1. Article

    Open Access

    GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy

    CRISPR/Cas9 system to treat human-related diseases has achieved significant results and, even if its potential application in cancer research is improving, the application of this approach in clinical practice...

    M Caforio, S Iacovelli, C Quintarelli in Journal of Experimental & Clinical Cancer … (2024)

  2. No Access

    Article

    S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation

    The p53 paralogues p73, p63 and their respective truncated isoforms have been shown to be critical regulators of developmental and differentiation processes. Indeed, both p73- and p63-deficient mice exhibit se...

    E Lapi, A Iovino, G Fontemaggi, A R Soliera, S Iacovelli, A Sacchi, G Rechavi in Oncogene (2006)